Sleep in patients with spontaneous panic attacks.
Twenty-four drug-free patients with a DSM-III diagnosis of panic disorders (and their age- and sex-matched normal controls) slept in the laboratory for 3 consecutive nights. Panic patients showed a slightly longer sleep latency and a lower sleep efficiency than their normal controls. They also had more overall movement time and more body movements during stage 2 sleep. Eight panic attacks were recorded arising out of sleep. Six of them occurred in the transition phase between stage 2 and stage 3 sleep. The nocturnal panic attacks of these patients are unique, different from stage 4 sleep terrors, and different from dream anxiety attacks.
Hauri
P J
PJ
Sleep Disorders Center, Mayo Clinic, Rochester, Minnesota 55905.
Friedman
M
M
Ravaris
C L
CL
D000293:Adolescent; D000328:Adult; D000525:Alprazolam / Q000627:therapeutic use; D002540:Cerebral Cortex / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects; D005239:Fear / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010200:Panic / Q000187:drug effects / Q000502:physiology*; D010698:Phobic Disorders / Q000188:drug therapy / Q000503:physiopathology*; D011433:Propranolol / Q000627:therapeutic use; D011930:Reaction Time / Q000502:physiology; D012894:Sleep Stages / Q000187:drug effects / Q000502:physiology*; D012893:Sleep Wake Disorders / Q000188:drug therapy / Q000503:physiopathology*; D012895:Sleep, REM / Q000502:physiology
D011433:Propranolol; D000525:Alprazolam